Full name
VALUEADD PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Scientific research and development activities
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.19.Z - Scientific research and development activities
82.92.Z - Packaging activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 29,1 | -2,6 | -3,2 | -21,6 |
EBITDA | -3,1 | -3,2 | -3,2 | 0,7 |
Short time liabilities | 0 | 0 | 0 | 0 |
Equity capital | 31,4 | 34 | 41,3 | 21,4 |
Operating profit (EBIT) | -3,1 | -3,2 | -3,2 | 0,7 |
Assets | 31,4 | 34 | 41,3 | 21,4 |
Net profit (loss) | 29,1 | 0 | -3,2 | ∞ |
Cash | 30,7 | 33,3 | 41,2 | 23,9 |
Liabilities and provisions for liabilities | 0 | 0 | 0 | 0 |
Net income from sale | 0 | 0 | 0 | 0 |
Working assets | 31,4 | 34 | 41,2 | 21,4 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 92,7 | 0 | -7,7 | -7,7 |
Equity capital to total assets | 100 | 100 | 100 | 0 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 0 | 0 | 0 |
Current financial liquidity indicator | ||||
Net dept to EBITDA | 9.755402565002441 | 10.392135620117188 | 12.967942237854004 | 2,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane